Revolution Medicines, Inc. (RVMDW) stock
RVMDWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMD
$9.81+0.18 (+1.82%)
Close on Oct 30, 2026Market cap $41.00BP/E –Yield –
Revolution Medicines enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Revolution Medicines's enterprise value was $35.09B on Oct 19, 2026, against $8.86B a year earlier. Over the last 5 years it ranged from $741.63M to $40.10B, with a median of $4.29B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $35.09B | +166.2% |
| 2025 | Dec 31, 2025 | $13.18B | +127.7% |
| 2024 | Dec 31, 2024 | $5.79B | +148.8% |
| 2023 | Dec 29, 2023 | $2.33B | +61.9% |
| 2022 | Dec 30, 2022 | $1.44B | +15.4% |
| 2021 | Dec 31, 2021 | $1.25B | -42.3% |
| 2020 | Dec 31, 2020 | $2.16B | – |